Taiwan FDA registration 283eb2d9cd8202297c386f41445255e4
DiaClon Anti-Leb
TW: "伯瑞" 單株抗體抗Leb鑑定卡片
Taiwan·Risk Class 2·MD·DIAMED GMBH·Registered Jul 20, 2022 – Jul 20, 2027ActiveRegistration details
- Analysis ID
- 283eb2d9cd8202297c386f41445255e4
- License Form
- Ministry of Health Medical Device Import No. 035682
- Customs Code
- DHA05603568209
Company information
- Manufacturer
- DIAMED GMBH
- Manufacturer Country
- Switzerland
- Authorized Representative
- Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.)
Product details
- Intended Use
- Detection of the Lewis antigen system on red blood cells using antigen-antibody responses.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B4020 Analyze specific reagents
- Import Information
- Imported from abroad; GMP
Dates and status
- Registration Date
- Jul 20, 2022
- Expiry Date
- Jul 20, 2027
About this record
Access comprehensive regulatory information for DiaClon Anti-Leb in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 283eb2d9cd8202297c386f41445255e4 and manufactured by DIAMED GMBH. The authorized representative in Taiwan is Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices